APYX Apyx Medical

Apyx Medical Corporation to Attend 15th Annual Craig-Hallum Alpha Select Conference

Apyx Medical Corporation to Attend 15th Annual Craig-Hallum Alpha Select Conference

CLEARWATER, Fla., Nov. 12, 2024 (GLOBE NEWSWIRE) -- Apyx Medical Corporation (NASDAQ:APYX) (“Apyx Medical;” the “Company”), the manufacturer of a proprietary helium plasma and radiofrequency platform technology marketed and sold as Renuvion®, today announced that Charles Goodwin, President and CEO and Matt Hill, CFO will be attending the following upcoming conference:

Event: 15th Annual Craig-Hallum Alpha Select Conference

Date: November 19, 2024

Location: Sheraton NY Times Square Hotel, New York, NY

Format: 1x1 Meetings

To request a meeting with Apyx, investors should contact their Craig Hallum representative.

About Apyx Medical Corporation:

Apyx Medical Corporation is an advanced energy technology company with a passion for elevating people’s lives through innovative products, including its Helium Plasma Platform Technology products marketed and sold as Renuvion in the cosmetic surgery market and J-Plasma® in the hospital surgical market. Renuvion and J-Plasma offer surgeons a unique ability to provide controlled heat to tissue to achieve their desired results. The effectiveness of Renuvion and J-Plasma are supported by more than 90 clinical documents. The Company also leverages its deep expertise and decades of experience in unique waveforms through OEM agreements with other medical device manufacturers. For further information about the Company and its products, please refer to the Apyx Medical Corporation website at .

Investor Relations Contact:

Jeremy Feffer, Managing Director LifeSci Advisors

OP: 212-915-2568

 



EN
12/11/2024

Underlying

APYXApyx Medical

To request access to management, click here to engage with our
partner Phoenix-IR's CorporateAccessNetwork.com

Reports on Apyx Medical

 PRESS RELEASE
Free
APYX APYX MEDICAL

Apyx Medical Corporation Reports Inducement Grant Under Nasdaq Listing...

Apyx Medical Corporation Reports Inducement Grant Under Nasdaq Listing Rule 5635(c)(4) CLEARWATER, Fla., Aug. 07, 2025 (GLOBE NEWSWIRE) -- Apyx Medical Corporation (NASDAQ:APYX) (“Apyx Medical”; the “Company”) today announced that on August 4, 2025, Apyx granted a nonstatuatory stock option to purchase 100,000 shares of common stock to John Featherstone, Apyx’s Vice President, North American Sales as a material inducement to such employee’s employment and in accordance with Nasdaq Listing Rule 5635(c)(4). The stock option has an exercise price of $1.85, the closing price of Apyx Medical ...

August 7, 2025 1 EN
 PRESS RELEASE
Free
APYX APYX MEDICAL

Apyx Medical Expands Global Sales Leadership with Strategic Hires to S...

Apyx Medical Expands Global Sales Leadership with Strategic Hires to Support AYON Launch and Accelerated Growth CLEARWATER, Fla., Aug. 07, 2025 (GLOBE NEWSWIRE) -- Apyx Medical Corporation, an advanced energy technology company and manufacturer of Renuvion® and the newly launched AYON Body Contouring System™, today announced the strategic appointments of two accomplished sales executives to its leadership team. These additions support the Company’s continued global expansion and the commercial launch of AYON, the industry’s first all-in-one surgical body contouring system. John Featherst...

August 7, 2025 1 EN
 PRESS RELEASE
Free
APYX APYX MEDICAL

Apyx Medical Corporation Reports Second Quarter 2025 Financial Results

Apyx Medical Corporation Reports Second Quarter 2025 Financial Results Successfully launched AYON Body Contouring System™ to key surgeons in critical geographies; plan for commercial launch in September 2025Initiated commercial sales of Renuvion® in China with strong clinical interest and completed initial proceduresBased on pre-sales of AYON, the Company increased its total revenue guidance for FY2025 to a range of $50.0 million to $52.0 millionManagement to host a conference call today at 4:30 p.m. ET CLEARWATER, Fla., Aug. 07, 2025 (GLOBE NEWSWIRE) -- Apyx Medical Corporation (NASDAQ...

August 7, 2025 1 EN
 PRESS RELEASE
Free
APYX APYX MEDICAL

Apyx Medical Corporation to Participate in the Canaccord Genuity 45th ...

Apyx Medical Corporation to Participate in the Canaccord Genuity 45th Annual Growth Conference CLEARWATER, Fla., July 30, 2025 (GLOBE NEWSWIRE) -- Apyx Medical Corporation (NASDAQ:APYX) (“Apyx Medical;” the “Company”), the manufacturer of a proprietary helium plasma and radiofrequency technology marketed and sold as Renuvion® and the AYON Body Contouring System™, today announced that management will participate in the Canaccord Genuity 45th Annual Growth Conference on Tuesday, August 12, 2025, in Boston, MA. Charlie Goodwin, the Company’s President and Chief Executive Officer, and Matt H...

July 30, 2025 1 EN
 PRESS RELEASE
Free
APYX APYX MEDICAL

Apyx Medical Corporation Announces Launch of Renuvion® in China

Apyx Medical Corporation Announces Launch of Renuvion® in China Strong clinical interest and early procedures completed Entered into distribution agreement with GlamMoon, a division of BeauCare Clinics Investment Co., Ltd. post-initial market clearance CLEARWATER, Fla., July 28, 2025 (GLOBE NEWSWIRE) -- Apyx Medical Corporation (NASDAQ:APYX) (“Apyx Medical”; the “Company”) today announced the launch of Renuvion® in China as part of its international commercialization strategy. A targeted sales and marketing campaign for Renuvion is being conducted through a distribution agreement cover...

July 28, 2025 1 EN

ResearchPool Subscriptions

Get the most out of your insights

Get in touch